ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)
China
· Delayed Price · Currency is CNY 42.61
-0.14 (-0.33%)
Mar 9, 2026, 4:00 PM EDT
ChengDa Pharmaceuticals Market Cap
ChengDa Pharmaceuticals has a market cap or net worth of 6.45 billion as of March 10, 2026. Its market cap has increased by 113.69% in one year.
Market Cap
6.45B
Enterprise Value
5.53B
Revenue
374.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.61
Market Cap Chart
Since January 20, 2022, ChengDa Pharmaceuticals's market cap has decreased from 12.43B to 6.45B, a decrease of -48.08%. That is a compound annual growth rate of -14.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 6.45B | 4.69% |
| Dec 31, 2025 | 6.16B | 101.68% |
| Dec 31, 2024 | 3.06B | -22.31% |
| Dec 29, 2023 | 3.93B | -19.91% |
| Dec 30, 2022 | 4.91B | -60.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Lianhuan Pharmaceutical | 6.47B |
| Beijing SL Pharmaceutical | 6.37B |
| Jinghua Pharmaceutical Group | 6.36B |
| Guizhou Xinbang Pharmaceutical | 6.30B |
| Tibet Duo Rui Pharmaceutical | 6.62B |
| Beijing Beilu Pharmaceutical | 6.18B |
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 6.76B |
| HPGC Renmintongtai Pharmaceutical | 6.13B |